Discovery of Potent and Selective Agonists of δ Opioid Receptor by Revisiting the “Message-Address” Concept

ACS Medicinal Chemistry Letters
2016.0

Abstract

The classic "message-address" concept was proposed to address the binding of endogenous peptides to the opioid receptors and was later successfully applied in the discovery of the first nonpeptide δ opioid receptor (DOR) antagonist naltrindole. By revisiting this concept, and based on the structure of tramadol, we designed a series of novel compounds that act as highly potent and selective agonists of DOR among which (-)-6j showed the highest affinity (K i = 2.7 nM), best agonistic activity (EC50 = 2.6 nM), and DOR selectivity (more than 1000-fold over the other two subtype opioid receptors). Molecular docking studies suggest that the "message" part of (-)-6j interacts with residue Asp128(3.32) and a neighboring water molecule, and the "address" part of (-)-6j packs with hydrophobic residues Leu300(7.35), Val281(6.55), and Trp284(6.58), rendering DOR selectivity. The discovery of novel compound (-)-6j, and the obtained insights into DOR-agonist binding will help us design more potent and selective DOR agonists.

Knowledge Graph

Similar Paper

Discovery of Potent and Selective Agonists of δ Opioid Receptor by Revisiting the “Message-Address” Concept
ACS Medicinal Chemistry Letters 2016.0
Application of the message-address concept in the design of highly potent and selective non-peptide .delta. opioid receptor antagonists
Journal of Medicinal Chemistry 1988.0
Design, Synthesis, and Biological Evaluation of 6α- and 6β-N-Heterocyclic Substituted Naltrexamine Derivatives as μ Opioid Receptor Selective Antagonists
Journal of Medicinal Chemistry 2009.0
Probes for Narcotic Receptor-Mediated Phenomena. 20. Alteration of Opioid Receptor Subtype Selectivity of the 5-(3-Hydroxyphenyl)morphans by Application of the Message-Address Concept: Preparation of .delta.-Opioid Receptor Ligands
Journal of Medicinal Chemistry 1995.0
A selective .delta.1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for .delta.1 opioid receptor agonists and antagonists
Journal of Medicinal Chemistry 1993.0
Opioid agonist and antagonist activities of morphindoles related to naltrindole
Journal of Medicinal Chemistry 1992.0
Synthesis and binding affinities of 4-diarylaminotropanes, a new class of delta opioid agonists
Bioorganic & Medicinal Chemistry Letters 2000.0
Optically pure (−)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzamide displays selective binding and full agonist activity for the δ opioid receptor
Bioorganic & Medicinal Chemistry Letters 1999.0
Synthesis, Pharmacology, and Molecular Docking Studies on 6-Desoxo-N-methylmorphinans as Potent μ-Opioid Receptor Agonists
Journal of Medicinal Chemistry 2017.0
N,N-Diethyl-4-[(3-hydroxyphenyl)(piperidin-4-yl)amino] benzamide derivatives: The development of diaryl amino piperidines as potent δ opioid receptor agonists with in vivo anti-nociceptive activity in rodent models
Bioorganic & Medicinal Chemistry Letters 2009.0